{"id":861828,"date":"2026-08-20T09:08:08","date_gmt":"2026-08-20T09:08:08","guid":{"rendered":"https:\/\/www.newsbeep.com\/au\/861828\/"},"modified":"2026-08-20T09:08:08","modified_gmt":"2026-08-20T09:08:08","slug":"weight-loss-drug-hope-for-alcohol-liver-obesity-patients","status":"publish","type":"post","link":"https:\/\/www.newsbeep.com\/au\/861828\/","title":{"rendered":"Weight Loss Drug: Hope for Alcohol, Liver, Obesity Patients"},"content":{"rendered":"\n<p>Scientists hope a weight loss drug already being used to treat obesity and diabetes could also benefit patients impacted by alcohol dependence and obesity, two of the biggest causes of liver disease.<\/p>\n<p>Semaglutide, also known as Wegovy, works by mimicking the GLP-1 hormone and has been shown to slow digestion and suppress appetite &#8211; now researchers are launching a trial to explore if it could be used to help people with alcohol dependency, obesity and liver disease.<\/p>\n<p>The four-year CURB (Controlling Unhealthy Relationships with Both alcohol and obesity) project is being funded by a grant of more than \u00a32.7million from the National Institute of Health and Care Research (NIHR), and will be co-led by the University of Plymouth, University Hospitals Plymouth NHS Trust, and the NIHR Biomedical Research Centre: Nottingham.<\/p>\n<p>Working with other UK partners, they will assess whether semaglutide does indeed reduce alcohol consumption in people with alcohol use disorder (AUD), obesity and liver disease.<\/p>\n<p>If the trial is successful, it is hoped the drug could change the way alcohol-related liver disease and obesity are treated, helping to guide future care in the UK and beyond.<\/p>\n<p>Alcohol use is one of the UK&#8217;s leading causes of death, costing the NHS \u00a35 billion each year, and harmful drinking is the country&#8217;s main cause of liver disease. About half of those living with alcohol-related liver disease are obese, and the combination of alcohol consumption and obesity can speed up liver damage and death.<\/p>\n","protected":false},"excerpt":{"rendered":"Scientists hope a weight loss drug already being used to treat obesity and diabetes could also benefit patients&hellip;\n","protected":false},"author":2,"featured_media":324640,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[10],"tags":[64,63,137],"class_list":["post-861828","post","type-post","status-publish","format-standard","has-post-thumbnail","category-health","tag-au","tag-australia","tag-health"],"_links":{"self":[{"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/posts\/861828","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/comments?post=861828"}],"version-history":[{"count":0,"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/posts\/861828\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/media\/324640"}],"wp:attachment":[{"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/media?parent=861828"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/categories?post=861828"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/tags?post=861828"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}